
zzso zzso zzso a zzso zzso was used to treat an zzso patient harboring a growth zzso zzso zzso zzso subcutaneous administration of zzso suppressed growth hormone and zzso growth zzso zzso levels and ameliorated clinical zzso zzso resonance imaging performed after 16 weeks revealed a zzso shrinkage of the zzso mass, with a zzso partially empty zzso zzso To document that this shrinkage occurred as a result of zzso treatment and not spontaneous tumor zzso the medication was withdrawn for 4 zzso A second magnetic resonance image disclosed regrowth of the tumor accompanied by rebound of growth hormone and zzso zzso zzso zzso zzso has been sustained with preservation of anterior zzso function since the drug was zzso These findings suggest that intermittent subcutaneous administration of zzso may provide potent medical zzso of growth zzso zzso 

